{
    "Trade/Device Name(s)": [
        "QuickScreen Pro Multi Drug Screening Test",
        "Model 9395Z",
        "Multi-Drug Urine Test Panel"
    ],
    "Submitter Information": "Phamatech, Inc.",
    "510(k) Number": "k181945",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070009"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "JXM",
        "DJC",
        "LFG",
        "DIS",
        "DIO",
        "DJR",
        "LDJ",
        "LCM",
        "DJG"
    ],
    "Summary Letter Date": "July 16, 2018",
    "Summary Letter Received Date": "July 20, 2018",
    "Submission Date": "October 15, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3620",
        "21 CFR 862.3650",
        "21 CFR 862.3870",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine and cocaine metabolite test system",
        "Methamphetamine test system",
        "Methadone test system",
        "Opiate test system",
        "Cannabinoid test system",
        "Tricyclic antidepressant drugs test system",
        "Phencyclidine (unclassified)"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cocaine",
        "Ecstasy",
        "Methadone",
        "Methamphetamine",
        "Opiates",
        "Oxycodone",
        "Phencyclidine",
        "Marijuana",
        "Tricyclic Antidepressants (Imipramine)",
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Antigen-antibody immunochemistry"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Screening test",
        "Single-use device"
    ],
    "Document Summary": "FDA 510(k) summary for QuickScreen Pro Multi Drug Screening Test Model 9395Z, a qualitative lateral flow immunoassay urine panel for drugs of abuse.",
    "Indications for Use Summary": "Screening test for qualitative detection of amphetamines, barbiturates, benzodiazepines, cocaine, ecstasy, methadone, methamphetamine, opiates, oxycodone, phencyclidine, marijuana, tricyclic antidepressants (imipramine), and buprenorphine in urine at specific cut-off concentrations for professional use; preliminary test requiring confirmatory method for positive results.",
    "fda_folder": "Toxicology"
}